Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 10/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL213208 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL10262394 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL6748385 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL5448 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL3690123 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL24214 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL15665811 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL1356717 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL3834 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE | |
| SCHEMBL15952 | 1.00 | PRKCA (0.52) | PRKCAMAPTMAPK1LMNAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1153619-A1 | Diaper having a lotioned topsheet | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-14 | — | — | EP | claimed |
| US-4627997-A | FLUORESCENT MATERIAL, COLORING AGENT, WAXES, BINDERS ON HEAT RESISTANT SUBSTRAGE; FORGERY PREVENTION | RICOH CO., LTD. (JP) | 1986-12-09 | — | — | US | claimed |
| CN-117802595-B | Polyhydroxyalkanoate monofilament and continuous preparation method thereof | 北京蓝晶微生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024090484-A1 | THERMOPLASTIC RESIN COMPOSITION | 株式会社カネカ | 2024-05-02 | — | — | WO | disclosed |
| CN-117802595-A | Polyhydroxyalkanoate monofilament and continuous preparation method thereof | 北京蓝晶微生物科技有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20240074973-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2024-03-07 | — | — | US | disclosed |
| US-20230407202-A1 | LUBRICATING OIL COMPOSITION, METHOD FOR USING LUBRICATING OIL COMPOSITION, AND METHOD FOR PRODUCING LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-12-21 | — | — | US | disclosed |
| US-20230365885-A1 | COMPLEX, AND METHOD FOR PRODUCING SAID COMPLEX | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-11-16 | — | — | US | disclosed |
| EP-4268827-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPINASTINE OR SALT THEREOF | Santen Pharmaceutical Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4269545-A1 | LUBRICATING OIL COMPOSITION, METHOD FOR USING LUBRICATING OIL COMPOSITION, AND METHOD FOR PRODUCING LUBRICATING OIL COMPOSITION | Idemitsu Kosan Co., Ltd (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-20230323114-A1 | ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF | KANEKA CORPORATION (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-0634290-A1 | Mass transferable donor ribbons for use in thermal dye transfer imaging | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0623479-A1 | Dye-donor ribbons for thermal transfer recording | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-11-09 | — | — | EP | disclosed |
| EP-0330411-B1 | Flame retardant for halogen-containing vinyl resins | NISSAN CHEMICAL IND LTD (JP) | 1994-01-26 | — | — | EP | disclosed |
| EP-0539001-A1 | Fluorescent colorant donor ribbons for thermal transfer imaging | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-04-28 | — | — | EP | disclosed |
| US-5190700-A | Antimony pentoxide, Alkali Metal Compound, Perchlorate, Hydrophobic Dispersant | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0185750-A4 | POWER TRANSFORMER FOR USE WITH VERY HIGH SPEED INTEGRATED CIRCUITS. | SHAW WILLIAM S | 1986-11-10 | — | — | EP | disclosed |
| EP-0185750-A1 | POWER TRANSFORMER FOR USE WITH VERY HIGH SPEED INTEGRATED CIRCUITS | SHAW, William S. (US) | 1986-07-02 | — | — | EP | disclosed |
| WO-1985005730-A1 | POWER TRANSFORMER FOR USE WITH VERY HIGH SPEED INTEGRATED CIRCUITS | SHAW WILLIAM S (US) | 1985-12-19 | — | — | WO | disclosed |
| US-4550364-A | Power transformer for use with very high speed integrated circuits | SHAW WILLIAM S | 1985-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074973-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF | ASAH2, ASAH1, ACER2 | PRKCA 2243/4885MAPT 2405/4885MAPK1 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.